Literature DB >> 17036379

Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

Peter-Laszlo Lakatos1.   

Abstract

Inflammatory bowel disease (IBD) is traditionally considered to be common in the Western world, and its incidence has sharply increased since the early 1950s. In contrast, until the last decade, low prevalence and incidence rates have been reported from other parts of the world including Eastern Europe, South America, Asia and the Pacific region. Recent trends indicate a change in the epidemiology of IBD with previously low incidence areas now reporting a progressive rise in the incidence, while in West European and North American countries the figures have stabilized or slightly increased, with decreasing incidence rates for ulcerative colitis. Some of these changes may represent differences in diagnostic practices and increasing awareness of the disease. The quality of studies is also variable. Additional epidemiologic studies are needed to better define the burden of illness, explore the mechanism of association with environmental factors, and identify new risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 17036379      PMCID: PMC4088101          DOI: 10.3748/wjg.v12.i38.6102

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  61 in total

1.  Asian ethnic origin and the risk of inflammatory bowel disease.

Authors:  S M Montgomery; D L Morris; R E Pounder; A J Wakefield
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-05       Impact factor: 2.566

2.  Changes in the incidence of inflammatory bowel disease: what does it mean?

Authors: 
Journal:  Eur J Intern Med       Date:  2000-08       Impact factor: 4.487

3.  Estimated incidence of inflammatory bowel disease in Argentina and Panama (1987-1993).

Authors:  J A Linares de la Cal; C Cantón; C Hermida; M Pérez-Miranda; J Maté-Jiménez
Journal:  Rev Esp Enferm Dig       Date:  1999-04       Impact factor: 2.086

4.  Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study.

Authors:  S Björnsson; J H Jóhannsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-01       Impact factor: 2.566

5.  Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995.

Authors:  E Lindberg; B Lindquist; L Holmquist; H Hildebrand
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-03       Impact factor: 2.839

6.  Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997.

Authors:  S K Yang; W S Hong; Y I Min; H Y Kim; J Y Yoo; P L Rhee; J C Rhee; D K Chang; I S Song; S A Jung; E B Park; H M Yoo; D K Lee; Y K Kim
Journal:  J Gastroenterol Hepatol       Date:  2000-09       Impact factor: 4.029

7.  Exposure to risk factors for ulcerative colitis occurs during an early period of life.

Authors:  F Delcò; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

8.  Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements.

Authors:  Y Niv; G Abuksis; G M Fraser
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

9.  Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore.

Authors:  Y M Lee; K Fock; S J See; T M Ng; C Khor; E K Teo
Journal:  J Gastroenterol Hepatol       Date:  2000-06       Impact factor: 4.029

10.  Inflammatory bowel disease: epidemiology and management in an English general practice population.

Authors:  G P Rubin; A P Hungin; P J Kelly; J Ling
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

View more
  127 in total

1.  Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.

Authors:  Zhaoxia Zhang; Chen Li; Xinmei Zhao; Chaolan Lv; Qiong He; Shan Lei; Yandong Guo; Fachao Zhi
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

Review 2.  MMX® Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis.

Authors:  Lily P H Yang; Paul L McCormack
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

3.  Typical gastroduodenal endoscopic findings in a Crohn's disease patient in remission stage.

Authors:  Masahiro Iizuka; Taku Harada; Hiro-O Yamano; Takeshi Etou; Shiho Sagara
Journal:  World J Gastrointest Endosc       Date:  2012-03-16

Review 4.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

Review 5.  Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease.

Authors:  Josep Bassaganya-Riera; Raquel Hontecillas
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-09       Impact factor: 4.294

Review 6.  Radiation enteropathy--pathogenesis, treatment and prevention.

Authors:  Martin Hauer-Jensen; James W Denham; H Jervoise N Andreyev
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-01       Impact factor: 46.802

Review 7.  Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis.

Authors:  C X W Tan; H S Brand; N K H de Boer; T Forouzanfar
Journal:  Br Dent J       Date:  2017-01-13       Impact factor: 1.626

8.  Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Authors:  Jan Seibel; Almut F Molzberger; Torsten Hertrampf; Ute Laudenbach-Leschowski; Patrick Diel
Journal:  Eur J Nutr       Date:  2009-02-21       Impact factor: 5.614

9.  Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon.

Authors:  Rowann Bowcutt; Lisa B Malter; Lea Ann Chen; Martin J Wolff; Ian Robertson; Daniel B Rifkin; Michael Poles; Ilseug Cho; P'ng Loke
Journal:  J Immunol Methods       Date:  2015-03-10       Impact factor: 2.303

Review 10.  Adenosine: an immune modulator of inflammatory bowel diseases.

Authors:  Jeff Huaqing Ye; Vazhaikkurichi M Rajendran
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.